Skip to main content

Table 1 One-year and two-year mortality rates among men with newly managed prostate cancer in 2009 by age and comparison with all male general scheme beneficiaries aged 40 and over, according to age after two years

From: Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality

  40-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85 and over All ages
Patients with cancer           
N 478 1,567 4,079 7,371 7,435 7,876 6,663 4,351 3,640 43,460
% 1.1 3.6 9.4 17.0 17.1 18.1 15.3 10.0 8.4 100.0
One-year follow-up           
Patients still alive* 443 1,481 3,857 7,026 7,070 7,368 6,022 3,568 2,526 39,361
Deceased           
N 15 40 101 186 242 392 532 727 1,047 3,282
% 3.3 2.6 2.6 2.6 3.3 5.1 8.1 16.9 29.3 4.6**
Two-year follow-up           
Patients still alive* 414 1,433 3,727 6,782 6,792 7,033 5,554 3,106 1,893 36,734
Deceased           
N 31 71 192 369 456 665 948 1,159 1,656 5,547
% 7.0 4.7 4.9 5.2 6.3 8.6 14.6 27.2 46.7 8.4**
SMR§ 11.4 3.7 2.6 2.1 1.9 1.8 1.9 2.1 1.9 2.0**
  1. *Excluding deaths, regime changes and patients lost to follow-up.
  2. **Age-standardised.
  3. §p < 0.001 for all SMR.